IP Verse

Esperion Therapeutics, Inc. V. Renata Limited - 2:24-cv-06017

Explore the details of the Esperion Therapeutics, Inc. V. Renata Limited case under case number 2:24-cv-06017 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:24-cv-06017
Filing Date
May 10, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ESPERION THERAPEUTICS, INC. -
RENATA LIMITED -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 22, 2024Notice of Request by Pro Hac Vice Ryan Curiel to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 250 receipt number ANJDC-15531893.) (WALSH, LIZA) (Entered: 07/22/2024)PACER Document
Jul 22, 2024Notice of Request by Pro Hac Vice Michelle Bone to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 250 receipt number ANJDC-15531886.) (WALSH, LIZA) (Entered: 07/22/2024)PACER Document
Jul 22, 2024Notice of Request by Pro Hac Vice John T. Bennett to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 250 receipt number ANJDC-15531876.) (WALSH, LIZA) (Entered: 07/22/2024)PACER Document
Jul 22, 2024STIPULATION AND ORDER FOR A SECOND-AMENDED COMPLAINT AND SETTING THE DEADLINE TO ANSWER OR OTHERWISE RESPOND TO SAME; Plaintiff shall file a second-amended complaint naming Somerset Therapeutics, LLC and Somerset Pharma, LLC as defendants in this litigation no later than July 26, 2024; Defendants, including Somerset Therapeutics, LLC and Somerset Pharma, LLC, consent that electronic service of the second-amended complaint in this litigation shall be sufficient as to all Defendants; The time for Renata to answer the First-Amended Complaint is hereby extended to August 2, 2024; Defendants, including Somerset Therapeutics, LLC and Somerset Pharma, LLC, shall serve their answer to the second-amended complaint no later than August 2, 2024. Signed by Magistrate Judge Cathy L. Waldor on 7/22/2024. (ld, ) (Entered: 07/23/2024)PACER Document
Jul 22, 2024ORDER Granting ECF No. 21, request for withdrawal of Counsel Stuart D. Sender and Amlan Ray. Signed by Magistrate Judge Cathy L. Waldor on 7/22/2024. (ld, ) (Entered: 07/23/2024)PACER Document
Jul 26, 2024AMENDED COMPLAINT (Second Amended Complaint) against RENATA LIMITED, SOMERSET THERAPEUTICS, LLC, SOMERSET PHARMA, LLC, filed by ESPERION THERAPEUTICS, INC..(WALSH, LIZA) (Entered: 07/26/2024)PACER Document
Jul 26, 2024Letter from Liza M. Walsh to the Honorable Cathy L. Waldor, U.S.M.J.. (WALSH, LIZA) (Entered: 07/26/2024)PACER Document
May 10, 2024COMPLAINT against RENATA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15359272), Related Case Selected, filed by ESPERION THERAPEUTICS, INC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet, # 4 AO 120 Form)(WALSH, LIZA) (Entered: 05/10/2024)Attachment
May 10, 2024COMPLAINT against RENATA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15359272), Related Case Selected, filed by ESPERION THERAPEUTICS, INC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet, # 4 AO 120 Form)(WALSH, LIZA) (Entered: 05/10/2024)Attachment
May 10, 2024COMPLAINT against RENATA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15359272), Related Case Selected, filed by ESPERION THERAPEUTICS, INC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet, # 4 AO 120 Form)(WALSH, LIZA) (Entered: 05/10/2024)Attachment
May 10, 2024COMPLAINT against RENATA LIMITED ( Filing and Admin fee $ 405 receipt number ANJDC-15359272), Related Case Selected, filed by ESPERION THERAPEUTICS, INC.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet, # 4 AO 120 Form)(WALSH, LIZA) (Entered: 05/10/2024)Attachment
Aug 2, 2024Corporate Disclosure Statement by RENATA LIMITED, SOMERSET PHARMA, LLC, SOMERSET THERAPEUTICS, LLC identifying Somerset Lifesciences, Inc. as Corporate Parent.. (MILLER, GREGORY) (Entered: 08/02/2024)PACER Document
Aug 2, 2024ANSWER to Amended Complaint, Defenses and, COUNTERCLAIM against ESPERION THERAPEUTICS, INC. by RENATA LIMITED, SOMERSET THERAPEUTICS, LLC, SOMERSET PHARMA, LLC.(MILLER, GREGORY) (Entered: 08/02/2024)PACER Document
Aug 23, 2024ANSWER to Counterclaim by ESPERION THERAPEUTICS, INC..(WALSH, LIZA) (Entered: 08/23/2024)PACER Document
Aug 23, 2024Letter from Liza M. Walsh to the Honorable Cathy L. Waldor, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(WALSH, LIZA) (Entered: 08/23/2024)PACER Document
Aug 26, 2024CONSENT ORDER FOR CONSOLIDATION that Civil Action Nos. 2:24-cv-05921, 2:24-cv-06017, 2:24-cv-06224, 2:24-cv-06263, 2:24-cv-06348, 2:24-cv-06391, 2:24-cv-06389, 2:24-cv-06386, and 2:24-cv-06387 (the "Consolidated Actions") are consolidated for all discovery and pretrial purposes, subject to further order of the Court; that all filings in the Consolidated Action shall use thefollowing caption going forward: In re Nexletol/Nexlizet ANDA Litigation; that all filings going forward shall be filed in Civil Action No. 2:24-cv-05921; that all counsel who have been admitted pro hac vice in any of the Consolidated Actions shall be deemed admitted pro hac vice in Civil Action No. 2:24-cv-05921. Signed by Magistrate Judge Cathy L. Waldor on 8/26/2024. (sm) (Entered: 08/27/2024)PACER Document
Jul 22, 2024Pro Hac Vice counsel, JOHN T. BENNETT, ESQ., MICHELLE BONE, ESQ., RYAN CURIEL, ESQ., COLBY DAVIS, ESQ., DOV HIRSCH, ESQ., ELIZABETH J. HOLLAND, ESQ., KATHERINE P. KIECKHAFER, ESQ., and NICHOLAS K. MITROKOSTAS, ESQ., has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (ld, )PACER Document
Jul 29, 2024TEXT ORDER: The Court has carefully considered counsel's letter dated 7/26/24 and will adjourn the initial conferences already scheduled in Civil Action Numbers 24-5921, 24-6224, and 24-6348 without date. The parties shall continue their discussions and Plaintiff's counsel shall file either a joint proposed consolidation order or a status update letter in the oldest matter - 24-5921 (Micro Labs) - on or before 8/23/24. So Ordered by Magistrate Judge Cathy L. Waldor on 7/29/24. (tjd) (Entered: 07/29/2024)PACER Document